Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma
Pediatric Blood & Cancer · 2026
DOI: 10.1002/1545-5017.70122 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Molly Mack und 12 weiteren Autor:innen. Beteiligte Einrichtung: University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Bone Neoplasms, DNA Repair Enzymes, DNA-Binding Proteins, Fanconi Anemia Complementation Group N Protein. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: UPMC Children's Foundation, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Approximately 10% of patients with Ewing sarcoma (EwS) have pathogenic germline variants. Here, we report two cases: first, a novel germline pathogenic variant in partner and localizer of BRCA2 ( PALB2) in a patient with a late EwS relapse. Its impact on homologous recombination is demonstrated, and breast cancer risk is discussed. Second, we report a pathogenic germline variant in RAD50 in a patient with a rare prostate primary EwS and later concurrent relapsed EwS and therapy‐related acute myeloid leukemia (tAML) with two rare KMT2A translocations. Understanding rare pathogenic germline variants and the impact on cancer behavior, response to treatment and treatment‐associated toxicities is important for patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Graduate Group in Biochemistry and Molecular Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Biochemistry and Biophysics, Penn Center for Genome Integrity, Basser Center for BRCA, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
- Department of Obstetrics and Gynecology, UPMC Magee-Women's Hospital, Pittsburgh, Pennsylvania, USA.
- Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Pediatrics, Mayo Clinic Children's, Mayo Clinic Comprehensive Cancer Center, Rochester, MN, USA.
Förderung
- UPMC Children's Foundation
- NIH HHS
- NCI NIH HHS
- National Cancer Institute
- National Institutes of Health
Zitieren
APA
Mack, M., Tufino, A. C., Jamalruddin, M. A., Dey, S., Pan, Y., Mukherjee, E., Daley, J. D., Meade, J., Aarabi, M., Maurer, L., Cooper, J., Bernstein, K. A., & Bailey, K. M. (2026). Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70122
Vancouver
Mack M, Tufino AC, Jamalruddin MA, Dey S, Pan Y, Mukherjee E, et al. Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70122
BibTeX
@article{Mack2026,
author = {Mack, Molly and Tufino, A Carolina and Jamalruddin, Mohd Azrin and Dey, Sreya and Pan, Yinghong and Mukherjee, Elina and Daley, Jessica D and Meade, Julia and Aarabi, Mahmoud and Maurer, Lisa and Cooper, James and Bernstein, Kara A and Bailey, Kelly M},
title = {Pathogenic Germline PALB2 and RAD50 Variants in Patients With Relapsed Ewing Sarcoma},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/1545-5017.70122}
}
EUVIMED